Recurrent respiratory papillomatosis: current and future perspectives

M Carifi, D Napolitano, M Morandi… - … and clinical risk …, 2015 - Taylor & Francis
Although recurrent respiratory papillomatosis is a benign disease of the upper aerodigestive
tract caused by infection with human papillomavirus, the disease process is unpredictable …

Current and future management of recurrent respiratory papillomatosis

R Ivancic, H Iqbal, B deSilva, Q Pan… - Laryngoscope …, 2018 - Wiley Online Library
Objectives Recurrent respiratory papillomatosis (RRP) is a chronic disease of the respiratory
tract that occurs in both children and adults. It is caused by the human papillomavirus (HPV) …

Bevacizumab as treatment option for recurrent respiratory papillomatosis: a systematic review

L Pogoda, F Ziylan, DPJ Smeeing, FG Dikkers… - European Archives of …, 2022 - Springer
Purpose To this day, there is no cure for recurrent respiratory papillomatosis (RRP). Multiple
surgical procedures are performed to achieve symptom relief and prevention of airway …

The use of the quadrivalent human papillomavirus vaccine (gardasil) as adjuvant therapy in the treatment of recurrent respiratory papilloma

DL Young, MM Moore, LA Halstead - Journal of Voice, 2015 - Elsevier
Objective To examine the effect of the quadrivalent human papillomavirus vaccine, Gardasil,
on the disease course of patients with recurrent respiratory papillomatosis (RRP). Methods A …

Recurrent respiratory papillomatosis: a 2020 perspective

JJ Benedict, CS Derkay - Laryngoscope investigative …, 2021 - Wiley Online Library
Objective Despite recent advancement recurrent respiratory papillomatosis (RRP) remains a
rare but challenging benign airway neoplasm. In recent years there has been significant …

Systemic bevacizumab for treatment of respiratory papillomatosis: international consensus statement

DR Sidell, K Balakrishnan, SR Best, K Zur… - The …, 2021 - Wiley Online Library
Objectives/Hypothesis The purpose of this study is to develop consensus on key points that
would support the use of systemic bevacizumab for the treatment of recurrent respiratory …

Long‐term follow‐up of parenteral bevacizumab in patients with recurrent respiratory papillomatosis

SA Ballestas, J Hidalgo Lopez, AM Klein… - The …, 2023 - Wiley Online Library
Objective The clinical course of recurrent respiratory papillomatosis (RRP) varies from
spontaneous remission to severe airway obstruction with wide variability in recurrence …

International Pediatric Otolaryngology Group (IPOG): Juvenile-onset recurrent respiratory papillomatosis consensus recommendations

C Lawlor, K Balakrishnan, S Bottero… - International journal of …, 2020 - Elsevier
Objectives To develop consensus recommendations for the evaluation and management of
juvenile-onset recurrent respiratory papillomatosis (JORRP) in pediatric patients. Methods …

Trends in recurrent respiratory papillomatosis treatment

SA Ballestas, S Shelly, RM Soriano, A Klein - Acta Otorrinolaringologica …, 2021 - Elsevier
Recurrent respiratory papillomatosis (RRP) consist of benign tumours along the airway
caused by human papillomavirus infection. Papillomas may cause changes in phonation …

Pharmacotherapy for recurrent respiratory papillomatosis (RRP): a treatment update

AJ Donne, A Kinshuck - Expert Opinion on Pharmacotherapy, 2021 - Taylor & Francis
Introduction: Recurrent respiratory papillomatosis is a rare human papillomavirus (HPV)-
induced condition where warts grow within the airway and especially the larynx to effect …